Basic Info

8100 Southpark Way, A-8
Littleton, CO 80120
(303) 730-1950
Preferred contact:
  Karen M Padgett - President/CEO
Novus Biologicals Inc
Business Identifier: Developing, licensing and marketing research materials to scientists in academic, corporate and government laboratories
Public Profile:
Novus Biologicals Inc was acquired by Bio-Techne in July 2014 for $60M. Novus supplies monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability to current research trends and needs

 Synopsis: Awardee Business Condition
Year Founded 1996 IP Holdings N/A
Employee Range 10-14 VC funded? No
Revenue Range 2.5M-5M Private/Public Privately Held
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
2000 1 NIH $99,953 Development of Antibodies to Study Oxidative DNA Damage


Media coverage